
COVID-19
Latest News
CME Content


A logistically complex undertaking is underway, unlike anything most of us have ever seen.

Research shows acetaminophen may dull the vaccine’s effects, while alcohol weakens the immune system

More information emerges on COVID-19’s ocular symptoms

Chris Wroten, OD covers how the recent COVID-19 stimulus bill affects ODs

This poll is for optometrists and eyecare professionals, only. It will close on Friday, January 22, 2021.

The speed at which the COVID-19 vaccine was developed is the medical breakthrough of our lifetimes.

We all share a common goal.

Cautious optimism for the coming year, according to practitioners

This poll is for optometrists and eyecare professionals, only. It will close on Friday, December 11, 2020.

When used in combination with remdesivir, baricitinib helps COVID-19 patients recover faster

COVID-19 is hitting some states harder than others

2 vaccine candidates compete to become first FDA-approved mRNA vaccine


This poll is for optometrists and eyecare professionals, only. It will close on Wednesday, November 25, 2020.

Considerations for eyecare providers to better care for their patients with diabetes

Coating masks in antiviral materials such as copper and silver may complement existing methods of limiting viral transmission

Encouraging news about the effectiveness of a COVID-19 vaccine candidate comes at a time when infection rates soar

Optometry is one big family

Azithromycin is a potential COVID-19 treatment, but a study warns it could increase the risk of cardiac events.

New technology and management options are going to continue to hit the market. How ODs approach each one of them will determine whether ODs benefit or not.


See our latest poll results

As remdesivir leads COVID-19 treatments, medications that are typically used to treat other conditions are being tested to see if any are effective against the virus.

Some 23 percent of children hospitalized with COVID-19 in Wuhan, China, had ocular manifestations